AIによる処方箋のコンプライアンス審査

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

AI技術を活用し、薬剤師の処方箋審査を支援し、薬物相互作用、投与量の誤り、禁忌を特定し、安全性と効率を向上させる。

プロンプト内容

コピー

Act as a senior clinical pharmacist to conduct a comprehensive review of the provided patient prescription data. First, extract key patient demographics, diagnosis, and all prescribed medications with their respective dosages. Second, cross-reference these details against current clinical guidelines and drug monographs to identify potential drug-drug interactions, contraindications, and dosage appropriateness relative to the patient's renal or hepatic function. Third, evaluate the rationale for any off-label uses and assess potential adverse effects. Finally, present your findings in a structured list, highlighting any safety concerns, recommended dosage adjustments, or areas requiring further clinical verification, ensuring the output is actionable and prioritizes patient safety.

コピー

ベテランの臨床薬剤師として、提供された患者の処方情報に対して詳細な審査を行ってください。まず、患者の基本情報、診断結果、および使用予定のすべての薬剤名と投与量を抽出します。次に、最新の臨床ガイドラインおよび添付文書に基づき、薬剤間の相互作用リスク、併用禁忌、および患者の肝腎機能状態に適合しているかどうかを個別に確認します。さらに、適応外使用の合理性と潜在的な副作用を重点的に調査します。最後に、発見された安全上の懸念、投与量の調整提案、またはさらに確認が必要な疑義点を明確に示す構造化リストの形式で結果を出力し、最終的な提案が高次臨床の実行可能性と安全性を備えていることを確保してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindication matching, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag any potential risks and provide optimization suggestions aligned with the latest clinical guidelines, ensuring the safety and efficacy of the medication regimen.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, checking for incompatibilities, verifying if dosages align with the patient's age and renal/hepatic function, and ensuring no contraindications are violated. List all identified risks and provide optimization suggestions or alternatives based on the latest clinical guidelines to ensure medication safety and regulatory compliance.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the following prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on evaluating the renal risks of NSAIDs in this patient population, check for drug-disease contraindications or dosage adjustment needs, and provide specific medication recommendations and risk warnings, ensuring the output is concise and professional.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.

処方箋審査アシスタント

Acting as a senior clinical pharmacist in a hospital pharmacy, please conduct a compliance review of the following electronic prescription. The input includes patient demographics, medical history, current medication list, and details of the proposed drug. First, analyze potential drug-drug interactions, particularly focusing on metabolic impacts for patients with hepatic or renal impairment. Next, verify if the dosage aligns with the latest clinical guidelines and patient weight calculations. Finally, identify any contraindications or allergy conflicts, and output the audit conclusion in structured yet natural language, clearly stating whether risks exist, their severity, and suggested adjustments to ensure patient safety.

処方審査アシスタント

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on analyzing the nephrotoxic risk of the NSAID Ibuprofen in such patients, evaluate its synergistic effect on blood pressure control with antihypertensives, and check for potential drug-disease interactions. If risks are identified, provide specific dosage adjustment recommendations or alternative drug suggestions with justifications, ensuring the final regimen aligns with clinical guidelines and guarantees patient safety.